LEADER 02210nam  2200517 a 450 
001 9910789981803321
005 20200520144314.0
010   $a1-61761-404-1
035   $a(CKB)2670000000091399
035   $a(EBL)3019255
035   $a(SSID)ssj0000473388
035   $a(PQKBManifestationID)12146597
035   $a(PQKBTitleCode)TC0000473388
035   $a(PQKBWorkID)10436736
035   $a(PQKB)11146193
035   $a(MiAaPQ)EBC3019255
035   $a(Au-PeEL)EBL3019255
035   $a(CaPaEBR)ebr10670820
035   $a(OCoLC)923660451
035   $a(EXLCZ)992670000000091399
100   $a20100625d2011      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aSqualene$b[electronic resource] $ecurrent knowledge and potential therapeutical uses /$fA. Rami?rez-Torres ... [et al.]
210   $aNew York $cNova Biomedical Books$d2011
215   $a1 online resource (85 p.)
225 1 $aBiotechnology in agriculture, industry and medicine
300   $aDescription based upon print version of record.
311   $a1-61728-974-4 
320   $aIncludes bibliographical references and index.
327   $aAntioxidant properties in vivo and in vitro -- Bioavailability of squalene in animal models and in human -- Squalene may neutralize different xenobiotics -- Squalene as an anti-inflammatory agent -- Squalene and atherosclerosis -- Anti-neoplastic properties of squalene -- Mechanisms of squalene action in cancer chemoprevention and regression -- A component of skin lipids and with a role in skin ageing and pathology -- Its use to boost antigenicity of several vaccines -- Other properties -- Toxicity at high levels of intake (neuropathy and pneumonia) -- Antibodies against squalene in certain individuals.
410  0$aBiotechnology in agriculture, industry and medicine.
606   $aSqualene$xThereapeutic use
615  0$aSqualene$xThereapeutic use.
676   $a615/.792
701   $aRami?rez-Torres$b A$01486691
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910789981803321
996   $aSqualene$93706265
997   $aUNINA